Source link : https://newshealth.biz/health-news/fda-approves-brain-tumor-drug-targeting-new-mutation/
(MedPage Today) — The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with diffuse midline glioma harboring H3 K27M mutations. Labeling stipulates use in individuals 1 year and… Source link : https://www.medpagetoday.com/hematologyoncology/braincancer/116869 Author : Publish date : 2025-08-06 21:20:00 Copyright for syndicated content belongs to the linked […]
The post FDA Approves Brain Tumor Drug Targeting New Mutation first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-06 21:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8